ATE536888T1 - Zusammensetzungen zur mehrstufigen anwendung von hot-spot-bestrahlung auf krebszellen - Google Patents
Zusammensetzungen zur mehrstufigen anwendung von hot-spot-bestrahlung auf krebszellenInfo
- Publication number
- ATE536888T1 ATE536888T1 AT05802465T AT05802465T ATE536888T1 AT E536888 T1 ATE536888 T1 AT E536888T1 AT 05802465 T AT05802465 T AT 05802465T AT 05802465 T AT05802465 T AT 05802465T AT E536888 T1 ATE536888 T1 AT E536888T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- cancer cells
- hot spot
- step application
- spot radiation
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000005855 radiation Effects 0.000 title abstract 2
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/897,530 US7615221B2 (en) | 2004-07-23 | 2004-07-23 | Compositions and methods for treating cancer |
| PCT/US2005/026248 WO2006010165A2 (en) | 2004-07-23 | 2005-07-25 | Compositions for multi-step delivery of hot-spots radiation to cancer cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE536888T1 true ATE536888T1 (de) | 2011-12-15 |
Family
ID=35657441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05802465T ATE536888T1 (de) | 2004-07-23 | 2005-07-25 | Zusammensetzungen zur mehrstufigen anwendung von hot-spot-bestrahlung auf krebszellen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7615221B2 (de) |
| EP (1) | EP1809332B1 (de) |
| JP (1) | JP2008507562A (de) |
| AT (1) | ATE536888T1 (de) |
| AU (1) | AU2005265425A1 (de) |
| CA (1) | CA2572825A1 (de) |
| WO (1) | WO2006010165A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5169064B2 (ja) * | 2007-08-09 | 2013-03-27 | 大日本印刷株式会社 | 可溶性ポルフィリン誘導体 |
| GB0901483D0 (en) * | 2009-01-29 | 2009-03-11 | Ge Healthcare Ltd | Radioiodination method |
| WO2019165171A2 (en) * | 2018-02-22 | 2019-08-29 | North Carolina State University | Compounds and methods useful in brachytherapy |
| CN114502171A (zh) * | 2019-07-25 | 2022-05-13 | 北卡罗莱纳州立大学 | 交联化合物及其使用方法 |
| WO2021092287A1 (en) * | 2019-11-08 | 2021-05-14 | North Carolina State University | Cross-linking compounds and methods of use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4892817A (en) * | 1987-09-21 | 1990-01-09 | Biogenex Laboratories | Stable phosphatase substrate composition |
| US5816259A (en) | 1997-01-13 | 1998-10-06 | Rose; Samuel | Method for the diagnosis and treatment of cancer by the accumulation of radioactive precipitates in targeted cells |
| US7807136B2 (en) | 1997-01-13 | 2010-10-05 | David S. Rose | Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic precipitates in the cancer |
| US6080383A (en) * | 1997-01-13 | 2000-06-27 | Rose; Samuel | Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancer |
| WO2002087497A2 (en) | 2001-04-26 | 2002-11-07 | Board Of Regents, The University Of Texas System | Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use |
| WO2004072238A2 (en) | 2003-02-05 | 2004-08-26 | Amersham Biosciences Corp | Terminal-phosphate-labeled nucleotides with new linkers |
-
2004
- 2004-07-23 US US10/897,530 patent/US7615221B2/en not_active Expired - Fee Related
-
2005
- 2005-07-25 CA CA002572825A patent/CA2572825A1/en not_active Abandoned
- 2005-07-25 WO PCT/US2005/026248 patent/WO2006010165A2/en not_active Ceased
- 2005-07-25 EP EP05802465A patent/EP1809332B1/de not_active Expired - Lifetime
- 2005-07-25 AT AT05802465T patent/ATE536888T1/de active
- 2005-07-25 AU AU2005265425A patent/AU2005265425A1/en not_active Abandoned
- 2005-07-25 JP JP2007522832A patent/JP2008507562A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005265425A1 (en) | 2006-01-26 |
| EP1809332A2 (de) | 2007-07-25 |
| EP1809332B1 (de) | 2011-12-14 |
| US20060018908A1 (en) | 2006-01-26 |
| US7615221B2 (en) | 2009-11-10 |
| WO2006010165A2 (en) | 2006-01-26 |
| CA2572825A1 (en) | 2006-01-26 |
| WO2006010165A3 (en) | 2007-02-08 |
| JP2008507562A (ja) | 2008-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020005463A (es) | Anticuerpos anti grupo de diferenciacion 47 (anti-cd47) y sus usos para tratar cancer. | |
| NO20084374L (no) | Imidazoltiazolforbindelser for behandling av sykdom | |
| SA520420658B1 (ar) | جزيئات ربط ضد bcma واستخداماتها | |
| DK1836169T3 (da) | Sammensætninger og fremgangsmåder til behandling af celleproliferationslidelser | |
| DK2010181T3 (da) | Fremgangsmåder til behandling af celleproliferative forstyrrelser under anvendelse af pyrimidindiamin- forbindelser | |
| EA201790962A1 (ru) | Терапевтические соединения и связанные с ними способы применения | |
| RU2448096C3 (ru) | Диарилгидантоины | |
| NI200900022A (es) | Anticuerpo especifico de prlr y usos del mismo | |
| EA200901653A1 (ru) | ОПОСРЕДУЕМОЕ PHKi ИНГИБИРОВАНИЕ ЭКСПРЕССИИ АЛЬФА-EnaC | |
| SG157365A1 (en) | Compositions and methods for treating neoplastic diseases | |
| EA201000673A1 (ru) | СПОСОБЫ И КОМПОЗИЦИИ ДЛЯ ИЗМЕРЕНИЯ АКТИВАЦИИ Wnt И ДЛЯ ЛЕЧЕНИЯ Wnt-ОПОСРЕДОВАННЫХ РАКОВЫХ ЗАБОЛЕВАНИЙ | |
| MY168762A (en) | Certain chemical entities, compositions and methods | |
| NO20091661L (no) | Anvendelse av pegylert IL-10 for a behandle kreft | |
| EP2118123A4 (de) | Stabilisierte p53-peptide und deren verwendungen | |
| EA200900819A1 (ru) | Хиназолины для ингибирования pdk1 | |
| EA200970737A1 (ru) | Оксабициклогептаны и оксабициклогептены, их получение и применение | |
| MX2009006505A (es) | Composiciones oftalmicas de estimulantes parasimpaticos y antiinflamatorios para usarlas en el tratamiento de la presbiopia. | |
| CY1119509T1 (el) | Συνθεσεις και μεθοδοι για ρυθμιστες αποπτωσης | |
| WO2009054939A8 (en) | Cancer classification and methods of use | |
| EA200971068A1 (ru) | Триазолиламинопиримидиновые соединения | |
| DE602006018709D1 (de) | Estergebundene geminitensidverbindungen zur verwendung in der gentherapie | |
| BR122018009866B8 (pt) | métodos para preparar compostos de éter aminocicloexílico e compostos intermediários | |
| WO2007065010A3 (en) | Anti-angiogenesis compounds | |
| PH12019500758A1 (en) | Pharmaceutical compositions and methods for the treatment of cancer | |
| MX2015006004A (es) | Inhibicion de celulas cancerosas resistentes a farmacos. |